Log in to save to my catalogue

Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with exci...

Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with exci...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6582098

Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs

About this item

Full title

Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs

Publisher

Cham: Springer International Publishing

Journal title

Journal of diabetes and metabolic disorders, 2019-06, Vol.18 (1), p.229-242

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Late onset Alzheimer’s disease (AD) is the most common cause of dementia among elderly. The exact cause of the disease is until now unknown and there is no complete cure for the disease. Growing evidence suggest that AD is a metabolic disorder associated with impairment in brain insulin signalling. These findings enriched the scope for the repurpos...

Alternative Titles

Full title

Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6582098

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6582098

Other Identifiers

ISSN

2251-6581

E-ISSN

2251-6581

DOI

10.1007/s40200-019-00405-2

How to access this item